Market Access

Product Launch Strategies: Adapting Approaches in 2020 and Beyond

June 01, 2020

Pharmaceutical Executive

With new access levers emerging, positioning products will require a shift form the traditional launch playbook.

Drive for COVID-19 Therapies Raises Patent and Pricing Issues

May 16, 2020

Pharmaceutical Executive

Proposals around the globe seek to ensure access to any promising treatments.

Market Access: From Being to Becoming

March 11, 2020

Pharmaceutical Executive

Examining the key learnings from BCG’s 2019 benchmark study-and the capabilities uncovered that will be critical to future performance.

Access-Based Commercial (ABC) Strategy for Drug Commercialization

March 06, 2020

Wolfram Lux and Simon Seiter discuss the implications of Strategic Market Access on work and processes, and its role in product planning and drug development success.

A Passion for Access: Banks Bourne, Tanner Pharma Group

March 06, 2020

Banks Bourne of Tanner Pharma Group talks about the organization's role in delivering access initiatives for products not commercially available in many parts of the world.

Is the Tail Wagging the Dog in Drug Market Entry?

January 13, 2020

Pharmaceutical Executive

Three product launch trends driven by emerging biopharma.

Market Access: Employers as Barriers to Value

December 18, 2019

Pharmaceutical Executive

Renewed education efforts by employers, however, are slowly helping them take back decision-making reins in their engagements with pharma.

Lundbeck's Taj Bhardwaj: Market Access and Mental Health

December 17, 2019

Pharmaceutical Executive

Lundbeck executive Taj Bhardwaj talks about the differing mindsets necessary to lead local and global-level market access strategy in pharma-and how his current company is committed to stay in the fight to advance new treatments and break down stigmas in mental health.

The Route to Market Access in Europe

December 17, 2019

Pharmaceutical Executive

Exploring the roadmap for US-based, R&D-focused biopharma companies seeking to successfully penetrate product markets and reach patients in Europe.

A Multi-Stakeholder Perspective On Assessing Drug Value

December 17, 2019

Pharmaceutical Executive

Industry working group identifies the value characteristics that may, collectively, become part of a shared approach to valuing pharmaceutical treatments.